Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.09 USD | +2.96% | -5.43% | +5.56% |
Mar. 08 | Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating | MT |
Mar. 05 | Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024 |
Financials (USD)
Sales 2024 * | 37.9M | Sales 2025 * | 35.29M | Capitalization | 187M |
---|---|---|---|---|---|
Net income 2024 * | -13M | Net income 2025 * | -29M | EV / Sales 2024 * | 4.94 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.3 x |
P/E ratio 2024 * |
-16.1
x | P/E ratio 2025 * |
-7.74
x | Employees | 68 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.62% |
Latest transcript on Compugen Ltd.
1 day | +2.96% | ||
1 week | -5.43% | ||
Current month | +8.29% | ||
1 month | -1.88% | ||
3 months | -9.13% | ||
6 months | +259.72% | ||
Current year | +5.56% |
Managers | Title | Age | Since |
---|---|---|---|
Anat Cohen-Dayag
CEO | Chief Executive Officer | 57 | 01-12-31 |
Alberto Sessa
DFI | Director of Finance/CFO | 61 | 22-10-31 |
Eran Ophir
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 65 | 17-10-01 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 18-06-10 |
Gilead Halevy
BRD | Director/Board Member | 57 | 18-06-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 2.09 | +2.96% | 205,128 |
24-05-13 | 2.03 | +1.00% | 163,156 |
24-05-10 | 2.01 | -3.83% | 271,884 |
24-05-09 | 2.09 | -1.88% | 106,608 |
24-05-08 | 2.13 | -3.62% | 188,656 |
Delayed Quote Nasdaq, May 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.56% | 187M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+43.45% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- CGEN Stock